Facing Funding Woes, Nucleonics Puts Itself On the Block, Begins Liquidating Lab Gear

Nucleonics’ decision to look for a buyer comes about eight months after its president and CEO said that the company was pursuing a $40 million Series C financing round, which could have been followed by an initial public offering.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.